342 related articles for article (PubMed ID: 16261404)
21. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.
Chanrion M; Fontaine H; Rodriguez C; Negre V; Bibeau F; Theillet C; Hénaut A; Darbon JM
BMC Cancer; 2007 Mar; 7():39. PubMed ID: 17338809
[TBL] [Abstract][Full Text] [Related]
22. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
Vincent-Salomon A; Lucchesi C; Gruel N; Raynal V; Pierron G; Goudefroye R; Reyal F; Radvanyi F; Salmon R; Thiery JP; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Delattre O;
Clin Cancer Res; 2008 Apr; 14(7):1956-65. PubMed ID: 18381933
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
[TBL] [Abstract][Full Text] [Related]
24. [Histopathologic diagnosis of luminal and basal type breast cancer].
Sarcević B
Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
[TBL] [Abstract][Full Text] [Related]
25. The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
Fadare O; Tavassoli FA
Adv Anat Pathol; 2007 Sep; 14(5):358-73. PubMed ID: 17717437
[TBL] [Abstract][Full Text] [Related]
26. Full-term pregnancy induces a specific genomic signature in the human breast.
Russo J; Balogh GA; Russo IH
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):51-66. PubMed ID: 18199711
[TBL] [Abstract][Full Text] [Related]
27. Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes.
Wennmalm K; Calza S; Ploner A; Hall P; Bjöhle J; Klaar S; Smeds J; Pawitan Y; Bergh J
Genes Chromosomes Cancer; 2007 Jan; 46(1):87-97. PubMed ID: 17044045
[TBL] [Abstract][Full Text] [Related]
28. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
Melchor L; Benítez J
Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
[TBL] [Abstract][Full Text] [Related]
29. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
30. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
Makretsov NA; Huntsman DG; Nielsen TO; Yorida E; Peacock M; Cheang MC; Dunn SE; Hayes M; van de Rijn M; Bajdik C; Gilks CB
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6143-51. PubMed ID: 15448001
[TBL] [Abstract][Full Text] [Related]
31. Molecular classification of breast cancer patients by gene expression profiling.
Ahr A; Holtrich U; Solbach C; Scharl A; Strebhardt K; Karn T; Kaufmann M
J Pathol; 2001 Oct; 195(3):312-20. PubMed ID: 11673828
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
34. Identifying tumor origin using a gene expression-based classification map.
Buckhaults P; Zhang Z; Chen YC; Wang TL; St Croix B; Saha S; Bardelli A; Morin PJ; Polyak K; Hruban RH; Velculescu VE; Shih IeM
Cancer Res; 2003 Jul; 63(14):4144-9. PubMed ID: 12874019
[TBL] [Abstract][Full Text] [Related]
35. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.
Poola I; DeWitty RL; Marshalleck JJ; Bhatnagar R; Abraham J; Leffall LD
Nat Med; 2005 May; 11(5):481-3. PubMed ID: 15864312
[TBL] [Abstract][Full Text] [Related]
36. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
Hayes DN; Monti S; Parmigiani G; Gilks CB; Naoki K; Bhattacharjee A; Socinski MA; Perou C; Meyerson M
J Clin Oncol; 2006 Nov; 24(31):5079-90. PubMed ID: 17075127
[TBL] [Abstract][Full Text] [Related]
38. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
39. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
40. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer.
Yakirevich E; Samkari A; Holloway MP; Lu S; Singh K; Yu J; Fenton MA; Altura RA
Hum Pathol; 2012 Jun; 43(6):865-73. PubMed ID: 22055399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
